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Introduction

The results of transplantation survival for 70 consecutive
cadaver kidneys preserved under hypothermic
pulsatile
perfusion at Henry Ford Hospital are reviewed. Pulsatile
perfusion for up to 30 hours did not adversely alter the
survival rate following transplantation. Thus, kidneys perfused for prolonged periods of time (> 20 hours) can be used
for transplantation, if the basic rules for organ retrieval and
preservation have been followed. Hypothermic
pulsatile
perfusion of cadaver kidneys has been demonstrated to be
an adequate
system for ex-vivo
preservation
for
transplantation.

A controversy exists as to whether or not cadaver kidney
preservation by hypothermic pulsatile perfusion diminishes
the long-term function of transplanted kidneys.^"^ Recently
Toledo-Pereyra and his colleagues^ reported that perfusion
of cadaver kidneys for morethan 30 hours did not adversely
affect either their long-term function after transplantation or
the onset of rejection. These findings have been confirmed
by Seim and his associates."
This paper presents the results o f a study of cadaver kidneys
harvested at several different hospitals and preserved under
hypothermic pulsatile perfusion by the Henry Ford Hospital
Preservation Team. All kidneys were transplanted at this
institution. Our study was designed to determine the influence of perfusion time on the short- and long-term funcfion
of 70 consecutive, perfused cadaver kidneys transplanted at
a single center.

Material and Methods
From July, 1973 to June, 1977, 70 cadaver kidneys were
perfused and transplanted to patients in end-stage renal
failure at Henry Ford Hospital. After transplantation, patients
were followed for a minimum of six months. All kidneys in
this study were preserved by hypothermic pulsatile perfusion for variable periodsof time. The actuarial survival of all
kidney transplants was calculated bythe method of Merrell
and Shulman.= All different variables among groups were
compared using 2 x 2 chi square statistical analysis.
Submitted for publication: February 15, 1978
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Standard methods were employed for harvesting all cadaver
kidneys. After nephrectomy, cold (4°C) Ringer's lactate
containing 10,000 U/L of heparin was usedto wash out the
blood in all kidneys until the venous effluent was clear. The
kidneys were then placed in the perfusion system at a
systolic perfusion pressure of 60 mm Hg, PO2 of 200 mm
Hg, pH of 7.4, and temperature of 7°C. The perfusate was
cryoprecipitated plasma, which contained the normal concentration of extracel I u lar electrolytes and osmolarity of 290
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mOsm/L. Routinely added tothe perfusate were ampicillin
(1.0 g m / L ) , m e t h y l p r e d n i s o l o n e (500 m g / L ) , phenolsulphonphthalein (PSP) (2ml/L), magnesium sulfate
50% (2 ml/L), and regular insulin (80 U/L).
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We discarded all kidneys wfth a flow of less than 0.3
m l / m i n / g m , a perfusion pressure of morethan 60 mm Hg,
and/orsevere vascular or ureteral abnormalities. The warm
ischemic time rarely exceeded five minutes. Cold ischemic
time from the time of cold flushing until the kidney was
placed in the perfusion machine rarely exceeded 15 minutes. Donor peripheral blood and lymph nodes removed at
the time of nephrectomy were used for histocompatability
testing. Recipient cytotoxic antibodies directed against
donor cells were studied by the microlymphocytotoxicity
method developed at the National Institute of Health.''
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The surgical transplant technique, immunosuppression, and
postoperative treatment remained relatively constant
throughout the study. The recipient immunosuppressive
dosage consisted of azathioprine 5.0 m g / K/day foroneday,
2.5 m g / K / d a y for 14 days, then 1.0-2.5 m g / K / d a y as the
white blood count indicated. Patients received prednisolone at a dose of 1.2 m g / K / d a y on the day of surgery,
then reduced by 2.0 mg each day to a maintenance dose of
10 to 30 mgdaily. As outpatients, they were randomized for
daily or alternate doses. Satisfactory renal function was
defined as that sufficient to sustain life without requiring
dialysis. Signs of graft failure were permanent restoration of
dialysis, graft removal, or patient death.
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Actuarial functional survival curves in 70 pertused cadaver kidney
transplants divided according to the length of perfusion. All causes of
kidney loss and death are included. In parentheses is the number of
transplants per group. There is an apparent trend for better survival w i t h
kidneys perfused for 21-30 hours than for those perfused for 11-20 hours,
although this is not statistically significant.
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Figure 1 shows that the actuarial survival rate of all perfused
cadaver kidneys wfthout exclusions. Fifty-three per cent of
the entire group of grafted kidneys were functioning at six
months. Thereafter, the loss of graft function was minimal up
to threeyears after transplantation. There were no significant
differences (p>0.08-0.5) among kidneys perfused for different intervals.

80
21-30

HRS

(13)

0 - 1 0 HRS

60

(10)

00
40

TOTAL (64)

<
cc

••O

1 1-20

O

HRS ( 4 1 )

20

12

Six renal grafts were lost due to technical errors within the
first month after transplantation. When these kidneys were
eliminated from the total group (Figure 2), data for shortterm and long-term function were improved, and the basic
pattern of survival among the different groups of perfused
kidneys for varying periods was maintained.
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Fig. 2

Actuarial functional survival curves in 64 perfused cadaver kidney
transplants divided according to the length of perfusion. Failures due to
technical factors were eliminated. A slight improvement over those in
Figure 1 is evident. In parentheses is the number of transplants in each
group.

It has been reported that diabetic patients do not survive as
well as nondiabetic patients after transplantation.' When
they were excluded from the study (Figure 3), there was a
tendency toward improved function from six months to
three years, although this improvement was not significant
(p>0.1-0.5). Figure 4 shows the actuarial survival rate of first
cadaver transplants only. The results followed a trend similar
to that observed in the entire transplant population.

As expected, patients under 40 years of age and with two or
more antigen matches did better than older patients and
those wfth fewer than two antigen matches (Figures 5,6).
Women in this study, contrary to other r e p o r t s , s h o w e d
better long-term function than men (Figure 7).
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The main causes of graft failure were rejection (30%),
infection (28%), and other causes associated with delayed
kidney function after transplantation (26%), such as acute
posttransplant renal failure and/or associated rejection. The
main causes of patient death were infecfion (73%), cardiac
(17%), and gastrointestinal bleeding (10%).
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In this study, we confirm the data from other institutions^""'^'^" that prolonged perfusion does not hinder longterm renal function after transplantation, nordoes it result in
an increased rate of rejection. In fact, cadaver kidneys
perfused for more than 20 hours had slightly better survival
rates than those perfused for 11 to 20 hours. Perfusion for
minimal periods (0-10 hrs) did not appear to be detrimental
for transplantation either.
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Although there has been considerable controversy about the
effect on cadaver kidney transplantation of hypothermic
pulsatile perfusion as opposed to hypothermic storage,^'^
the data of Toledo-Pereyra and his associates,^ as well as that
from the Human Renal Transplant Registry," showed no
significant differences in graft function between perfused
and cold-stored kidneys. Toledo-Pereyra and his groups
indicated in a prospective and controlled comparative study
that perfused kidneys did better than cold-stored kidneys.
Other studies carried out by Payne et a l " demonstrated
clinically and experimentally that kidneys perfused by
hypothermic pulsatile perfusion for 24 to 48 hours had
equal or better survival than unperfused grafts or those
preserved by cold storage. In this paper, we can say only that

Actuarial functional survival curves of cadaver kidney transplants, excluding transplants of diabetic patients. In parentheses is the number of
transplants per group.

In our search for the ideal risk patient, we eliminated
diabetic recipients, patients over 40, and those who had
received multiple transplants (Figure 8). The overall survival
was improved. Again, the length of perfusion did not
adversely affect the perfused kidneys.
Perfused kidneys that did not function immediately after
transplantation did not survive as well over the long term as
those that had immediate function (Figure 9). However,
kidneys that recovered function after dialysis had excellent
long-term survival.
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Fig. 4
Actuarial functional survival curves of all first cadaver kidney transplants. In parentheses is the number of transplants per group. When multiple transplants
are excluded, slight improvement over those in Figure 2 is evident.
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Fig. 5
Actuarial functional curves of perfused cadaver kidney transplants comparing age and length of perfusion. Patients over 40 do less well than those under 40.
Prolonged perfusion does not adversely affect long-term transplant function. In parentheses is the number of transplants per group.
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Fig. 6
Actuarial functional survival curves of cadaver kidney transplants comparing antigen matching in perfused kidneys. Kidneys w i t h t w o or more antigen
matches did better than those w i t h one or fewer antigen match. In parentheses is the number of transplants per group.

the length of perfusion is not an adverse factor in cadaver
kidney transplantation.

Contrary to the reports of others,^'^^ our data indicate that
kidneys which did not function promptly after transplantation did not do as well as those kidneys that began to
function immediately. If kidney function did return, complete recovery was observed. Prolonged preservation under
the conditions described had no detrimental effect on
immediate kidney function. There was a similar incidence of

In general, our data corroborate the detrimental effect of
high-risk factors in cadaver transplantation, such as age,
diabetes mellitus, and multiple transplantation. Antigen
matching also correlated w e l l w i t h long-term kidney
function.
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Fig. 7
Actuarial functional curves of cadaver kidney transplants in men and women. Women did better than men. Kidneys perfused for 21-30 hours had a better
trend of survival in women than in the other groups.
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Fig. 8

Actuarial functional curves of first cadaver kidney transplants after
diabetics and patients over 40 years old are eliminated. When compared
to those in Figure 2, there is overall improvement in long-term function, in
parentheses is the number of transplants per group.

nonfunction in all groups of perfused kidneys, regardless of
the length of perfusion.
In short, in this study we demonstrate that hypothermic
pulsatile perfusion of kidneys is an adequate means of exvivo preservation for transplantation.
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Fig. 9
Actuarial functional survival curves of perfused cadaver kidneys comparing immediate function after transplantation. Kidneys w i t h immediate function did
better than those that did not function immediately after transplantation.
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